Most MS Patients Who Received Stem Cell Transplants Still in Remission 3 … – Healthline
Healthline |
Most MS Patients Who Received Stem Cell Transplants Still in Remission 3 …
Healthline Most of the multiple sclerosis (MS) patients who took part in the cutting-edge stem cell study HALT-MS are still in remission years later. The phase 2 study has demonstrated impressive results by rebuilding the immune system using a patient's own stem … |
